Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NUVB is expected to report earnings to -17 cents per share on November 05
Q3'25
Est.
$-0.17
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
The last earnings report on August 07 showed earnings per share of -17 cents, meeting the estimate of -17 cents. With 4.46M shares outstanding, the current market capitalization sits at 941.25M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVB showed earnings on August 07, 2025. You can read more about the earnings report here.